Bridging Molecular Research and Clinical Application
Professor Fenyö, currently a professor at New York University, holds a PhD in Physics from Uppsala University and has spent more than three decades at the forefront of research in artificial intelligence, proteomics, bioinformatics and clinical medicine. His research aims for a detailed understanding of the dynamics of cellular processes, applying mathematical, statistical and computational methods to solve practical problems in experimental design optimization, quantitative data analysis and biological system modelling. A central focus of his work is proteomic data analysis, where he develops computational methods and databases for protein identification, characterization and quantitation using mass spectrometry-based proteomics.
At WCMM, Professor Fenyö will establish multimodal foundation models that combine digital pathology, clinical sequencing, and electronic health record data. These models are designed to accelerate the translation of molecular discoveries into patient-relevant insights, supporting both pre-clinical and clinical research groups. His efforts will also complement national initiatives, including SciLifeLab, DDLS and MAX IV, positioning Lund University as a hub for computational medicine and data-intensive life science.
By bridging molecular research and clinical application, Professor Fenyö’s program will not only enhance Lund University’s research capabilities but also create new opportunities for cross-disciplinary collaborations, fostering synergies between bioinformatics, oncology, molecular medicine and digital health.
Advancing Research, Mentorship and Innovation
In addition to his scientific contributions, Professor Fenyö is highly regarded for his mentorship and leadership. He has a strong track record of supporting early-career researchers, fostering and masters doctoral training programs, and building collaborative research environments. His presence at WCMM is expected to strengthen career pathways, support next-generation research leaders, and provide opportunities for interdisciplinary PhD projects in partnership with DDLS and other national initiatives.
Professor Fenyö also brings extensive experience in innovation and entrepreneurship, making him well-positioned to connect local innovation hubs with national and international research initiatives. His work in translating scientific discoveries into practical tools and business concepts aligns closely with Sweden’s Life Science Strategy and ongoing efforts to promote research-driven innovation.
“This recruitment represents a strategic investment for WCMM and Lund University,” says Gunilla Westergren Thorsson, Director WCMM Lund. “Professor Fenyö’s interdisciplinary approach, translational vision, and international expertise will expand our research capabilities, accelerate progress toward precision medicine, and strengthen Sweden’s global leadership in life science.”